To sustain this infrastructure and national capability, Texas A&M CIADM is responsible for training the next generation of biopharmaceutical manufacturing professionals who will be responsible for the production of on-demand vaccines, therapeutics, and medical countermeasures.  These individuals will receive theoretical and hands-on training in both fundamental and emerging technologies in areas including (but not limited to) cGMP, quality, regulatory compliance, biosafety, upstream and downstream manufacturing processes, process development and scale-up, documentation and standard operating procedures, process control, and automation. To date, there are 26 course series comprised of more than 120 individual curriculum modules under development which allow for maximal degree and certificate customization and flexibility. Find more detailed information about course offerings.

The Workforce Development Program is based at the National Center for Therapeutics Manufacturing (NCTM), a first-of-its-kind, interdisciplinary biopharmaceutical education center located at Texas A&M University in College Station.  The NCTM’s well-appointed analytical and wet labs, cell culture suite, conference halls, simulation software training laboratory, and fully-equipped cGMP training suite – outfitted with cutting-edge upstream and downstream bioprocess equipment – provide some of the most interactive and realistic pharmaceutical manufacturing training environments available on the market today. All NCTM training is developed and delivered by industry-experienced professionals and academic subject matter experts from a variety of disciplines and institutions.  

CIADM Workforce Development partners include:

  • Texas A&M University
  • Texas A&M Engineering Experiment Station (TEES)
  • Texas A&M Engineering Extension Service (TEEX)
  • National School of Tropical Medicine at Baylor College of Medicine
  • Blinn College
  • Leading pharmaceutical industry subject matter experts